NOVAVAX INC (NVAX)       16.52  -0.33 (-1.96%)

16.52  -0.33 (-1.96%)

US6700024010 - Common Stock - After market: 16.4 -0.12 (-0.73%)

EPS Estimates (USD)

Recent Earnings VS Estimates
Period Reported Estimate Difference Surprise Q3 2022 -2.15 1.60 -3.75-234.40% Q2 2022 -6.53 5.61 -12.14-216.36% Q1 2022 2.56 2.75 -0.19-6.76% Q4 2021 -11.18 -1.84 -9.34-508.26% Q3 2021 -4.31 -3.98 -0.33-8.16% Q2 2021 -4.75 -3.70 -1.05-28.22% Q1 2021 -3.05 -3.67 0.6216.89% Q4 2020 -2.70 -1.52 -1.18-77.46%
Future EPS Estimates
Period Estimate Prior Growth (Y2Y) FY 2022 -0.84 -23.29 96.38%Q4 2022 -0.66 -11.18 94.05%FY 2023 -3.94 -0.84 -366.93%Q1 2023 -1.85 2.56 -172.12%Q2 2023 -1.74 -6.53 73.29%Q3 2023 -1.08 -2.15 49.71%Q4 2023 -0.02 -0.66 97.70%FY 2024 -1.96 -3.94 50.32%FY 2025 0.96 -1.96 149.02%FY 2026 2.40 0.96 150.00%

Revenue Estimates (USD)

Recent Revenue VS Estimates
Period Reported Estimate Difference Surprise Q3 2022 734.577M 597.97M 136.607M22.85% Q2 2022 185.925M 1.037B -851.075M-82.07% Q1 2022 703.971M 862.11M -158.139M-18.34% Q4 2021 222.2M 338.43M -116.23M-34.34% Q3 2021 178.844M 341.31M -162.466M-47.60% Q2 2021 298.017M 395.63M -97.613M-24.67% Q1 2021 447.2M 238.58M 208.62M87.44% Q4 2020 279.7M 310.98M -31.28M-10.06%
Future Revenue Estimates
Period Estimate Prior Growth (Y2Y) FY 2022 2.079B 1.146B 81.37%Q4 2022 432.84M 222.2M 94.80%FY 2023 1.462B 2.079B -29.68%Q1 2023 413.1M 703.971M -41.32%Q2 2023 413.1M 185.925M 122.19%Q3 2023 515.1M 734.577M -29.88%Q4 2023 731.34M 432.84M 68.96%FY 2024 1.373B 1.462B -6.09%FY 2025 1.106B 1.373B -19.47%FY 2026 907.939M 1.106B -17.88%